» Articles » PMID: 20187211

Multiparametric Magnetic Resonance Imaging for the Differentiation Between Benign and Malignant Salivary Gland Tumors

Overview
Date 2010 Feb 27
PMID 20187211
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the stepwise approach in differentiating between benign and malignant salivary gland tumors using time-intensity curves (TICs) and apparent diffusion coefficients (ADCs).

Materials And Methods: TICs and ADCs were analyzed on the tumor-by-tumor (overall) and pixel-by-pixel (TIC and ADC maps) bases in patients with benign (n = 52) or malignant (n = 18) salivary gland tumor. TICs were categorized into Types 1 (<20% increment ratio), 2 (>or=20% increment ratio and >120 sec peak time), 3 (>or=20% increment ratio, <or=120 sec peak time, and <30% washout ratio), or 4 (>or=20% increment ratio, <or=120 sec peak time, and >or=30% washout ratio). ADCs were classified as extremely low (<0.6 x 10(-3) mm(2)/sec), low (<1.2), intermediate (<1.8), or high (>or=1.8).

Results: Malignant tumors had small (<30%) areas with Type 1 TIC with one of the following magnetic resonance imaging (MRI) characteristics: Type 3 overall TIC patterns, Type 4 overall TIC patterns and extremely low (<0.60 x 10(-3) mm(2)/sec) overall ADCs, or Type 2 overall TIC patterns and large (>40%) areas with low or extremely low ADCs.

Conclusion: We propose a stepwise approach by using multiparametric MRI techniques as an effective tool for differentiating between benign and malignant salivary gland tumors.

Citing Articles

Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors.

Gokce E, Beyhan M World J Radiol. 2023; 15(1):20-31.

PMID: 36721673 PMC: 9884336. DOI: 10.4329/wjr.v15.i1.20.


Radiomic Analysis of Multi-parametric MR Images (MRI) for Classification of Parotid Tumors.

Kazerooni A, Nabil M, Alviri M, Koopaei S, Salahshour F, Assili S J Biomed Phys Eng. 2022; 12(6):599-610.

PMID: 36569565 PMC: 9759641. DOI: 10.31661/jbpe.v0i0.2007-1140.


The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now?.

Cleymaet R, Vermassen T, Coopman R, Vermeersch H, De Keukeleire S, Rottey S Int J Mol Sci. 2022; 23(23).

PMID: 36499216 PMC: 9740091. DOI: 10.3390/ijms232314891.


Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?.

Vernuccio F, Arnone F, Cannella R, Verro B, Comelli A, Agnello F Br J Radiol. 2021; 94(1128):20210340.

PMID: 34591597 PMC: 8631014. DOI: 10.1259/bjr.20210340.


Differentiation of Benign and Malignant Parotid Gland Tumors with MRI and Diffusion Weighted Imaging.

Percem Orhan Soylemez U, Atalay B Medeni Med J. 2021; 36(2):138-145.

PMID: 34239766 PMC: 8226408. DOI: 10.5222/MMJ.2021.84666.